• Celgene In Talks To Buy Juno Therapeutics

    New York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.

    Jan 17, 2018
  • Has Bio-IT Soured On Cloud?

    Bio-IT World | Bio-IT has swung the gamut of opinions on cloud solutions. First wary, then warming, now, perhaps, pulling back. The inconsistency comes as use cases evolve and costs are closely watched. But there’s no denying that the cloud lets researchers do things they’ve never done before. The trick is finding the right balance.

    Jan 17, 2018
  • Howard Jacob Leaving HudsonAlpha For AbbVie

    Bio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.

    Jan 16, 2018
  • DNA Sequencing Holds Some Promise For Treating Tumors

    NPR | Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.

    Jan 15, 2018
  • 23andMe CEO Goes Beyond “Wall Of A White Coat”

    Bio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.

    Jan 15, 2018
  • JP Morgan 2018 News Roundup

    Bio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.

    Jan 12, 2018
  • Nonprofit Price For New Childhood Blindness Therapy 4X Too High

    STAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.

    Jan 12, 2018
  • Illumina Announces iSeq 100, Thermo Fisher Partnership

    Bio-IT World  In the company’s JP Morgan presentation today, Illumina president and CEO Francis deSouza summarized the past year for the sequencing giant, highlighted expected areas of growth—consumer genomics, non-invasive prenatal testing—and announced the launch of the iSeq 100 Sequencing System and library prep partnership with Thermo Fisher.

    Jan 8, 2018
  • Genomics England Uses DRAGEN Pipeline To Re-Analyze 5000 Whole Genomes

    Bio-IT World Brief  Genomics England is currently using Edico Genome’s DRAGEN analysis pipeline to re-process 5,000 whole human genomes from individuals with rare diseases. Genomics England and Edico announced the partnership today at the annual J.P. Morgan Healthcare Conference.

    Jan 8, 2018